4.5 Article

The Wheat Germ Agglutinin-Fractionated Proteome of Subjects With Alzheimer's Disease and Mild Cognitive Impairment Hippocampus and Inferior Parietal Lobule: Implications for Disease Pathogenesis and Progression

Journal

JOURNAL OF NEUROSCIENCE RESEARCH
Volume 88, Issue 16, Pages 3566-3577

Publisher

WILEY
DOI: 10.1002/jnr.22528

Keywords

proteomics; wheat germ agglutinin; lectin affinity chromatography; mass spectrometry; Alzheimer's disease; amnestic mild cognitive impairment

Categories

Funding

  1. NIH [AG-05119, AG-10836]
  2. Istituto Pasteur-Fondazione Cenci Bolognetti

Ask authors/readers for more resources

Lectin affinity chromatography is a powerful separation technique that fractionates proteins by selectively binding to specific carbohydrate moieties characteristic of protein glycosylation type. Wheat germ agglutinin (WGA) selectively binds terminal N-acetylglucosamine (O-GlcNAc) and sialic acid moieties characteristic of O-linked glycosylation. The current study utilizes WGA affinity chromatography to fractionate proteins from hippocampus and inferior parietal lobule (IPL) from subjects with Alzheimer's disease (AD) and arguably its earliest form, mild cognitive impairment (MCI). Proteins identified by proteomics that were fractionated from MCI and AD hippocampus by WGA affinity chromatography with altered levels compared with age-matched controls included GP96, gamma-enolase, glutamate dehydrogenase, glucosidase Il alpha, 14-3-3 epsilon, 14-3-3-gamma, 14-3-3 zeta, tropomyosin-2, calmodulin 2, gelsolin, beta-synuclein, alpha 1-antichymotrypsin, and dimethylguanosine tRNA methyltransferase. Proteins identified by proteomics that were fractionated from MCI and AD IPL by WGA affinity chromatography showing altered levels compared with age-matched controls included protein disulfide isomerase, calreticulin, and GP96. The proteins described in this study are involved in diverse processes, including glucose metabolism, endoplasmic reticulum (ER) functions, chaperoning, cytoskeletal assembly, and proteolysis, all of which are affected in AD. This study, the first to use proteomics to identify WGA-fractionated proteins isolated from brains from subjects with MCI and AD, provides additional information about the active proteome of the brain throughout AD progression. (C) 2010 Wiley-Liss, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome

Ilaria Zuliani, Chiara Lanzillotta, Antonella Tramutola, Antonio Francioso, Sara Pagnotta, Eugenio Barone, Marzia Perluigi, Fabio Di Domenico

Summary: Protein O-GlcNAcylation plays a crucial role in neurodegenerative diseases, particularly in the pathogenesis of Alzheimer's disease. Although Down syndrome (DS) and AD share similar pathological features, the impact of O-GlcNAcylation in DS pathology has not been investigated. This study sheds light on the role of O-GlcNAcylation in DS brain alterations and its significance in AD hallmarks.

NEUROTHERAPEUTICS (2021)

Article Biochemistry & Molecular Biology

Insulin resistance, oxidative stress and mitochondrial defects in Ts65dn mice brain: A harmful synergistic path in down syndrome

Chiara Lanzillotta, Antonella Tramutola, Graziella Di Giacomo, Federico Marini, D. Allan Butterfield, Fabio Di Domenico, Marzia Perluigi, Eugenio Barone

Summary: Research has shown that Down syndrome shares many common features with early onset Alzheimer's disease, including defects in brain insulin resistance, oxidative stress, and protein activation status in synaptic plasticity mechanisms. These abnormalities appear early in DS model mice, which may contribute to the development of AD in DS.

FREE RADICAL BIOLOGY AND MEDICINE (2021)

Review Biochemistry & Molecular Biology

Stress Responses in Down Syndrome Neurodegeneration: State of the Art and Therapeutic Molecules

Chiara Lanzillotta, Fabio Di Domenico

Summary: Down syndrome is characterized by early onset Alzheimer's disease due to triplication of genes on chromosome 21, leading to oxidative stress and protein oxidation. Therapeutic approaches targeting antioxidant response and protein stability have shown efficacy in murine models, but further studies are needed for clinical translation.

BIOMOLECULES (2021)

Article Biochemistry & Molecular Biology

High-Fat Diet Leads to Reduced Protein O-GlcNAcylation and Mitochondrial Defects Promoting the Development of Alzheimer's Disease Signatures

Ilaria Zuliani, Chiara Lanzillotta, Antonella Tramutola, Eugenio Barone, Marzia Perluigi, Serena Rinaldo, Alessio Paone, Francesca Cutruzzola, Francesco Bellanti, Matteo Spinelli, Francesca Natale, Salvatore Fusco, Claudio Grassi, Fabio Di Domenico

Summary: This study reveals that aberrant protein O-GlcNAcylation plays a significant role in the neurodegenerative process induced by a high-fat diet, potentially promoting the development of Alzheimer's disease and mitochondrial impairment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder

M. Perluigi, F. Di Domenico, E. Barone, D. A. Butterfield

Summary: Alzheimer's disease (AD) is the most common form of dementia in the elderly, with aberrant mTOR signaling potentially leading to cognitive decline and increased oxidative stress, impacting disease progression.

FREE RADICAL BIOLOGY AND MEDICINE (2021)

Article Clinical Neurology

Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal-derived extracellular vesicles

Marzia Perluigi, Anna Picca, Elita Montanari, Riccardo Calvani, Federico Marini, Roberto Matassa, Antonella Tramutola, Alberto Villani, Giuseppe Familiari, Fabio Di Domenico, D. Allan Butterfield, Kenneth J. Oh, Emanuele Marzetti, Diletta Valentini, Eugenio Barone

Summary: The study found that nEVs isolated from DS children showed a significant increase in insulin resistance marker pIRS1(Ser636) and hyperactivation of the Akt/mTOR/p70S6K pathway downstream from IRS1, possibly driven by higher inhibition of PTEN. Additionally, high levels of pGSK3 beta(Ser9) were also observed. These alterations in the insulin-signaling/mTOR pathways are believed to be early events in the DS brain, contributing to the cognitive dysfunction and intellectual disability seen in this unique population.

ALZHEIMERS & DEMENTIA (2022)

Meeting Abstract Biochemistry & Molecular Biology

The Interplay Among Oxidative Stress, Brain Insulin Resistance and AMPK Dysfunction Contribute to Neurodegeneration in Type 2 Diabetes and Alzheimer Disease

D. Allan Butterfield, Eugenio Barone, Fabio Di Domenico, Marzia Perluigi

FREE RADICAL BIOLOGY AND MEDICINE (2022)

Article Biochemistry & Molecular Biology

The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease

Eugenio Barone, Fabio Di Domenico, Marzia Perluigi, D. Allan Butterfield

Summary: The article discusses the potential relationship between type 2 diabetes and Alzheimer's disease, highlighting the roles of oxidative stress, insulin resistance, and AMPK dysfunction in neurodegenerative disorders.

FREE RADICAL BIOLOGY AND MEDICINE (2021)

Article Biochemistry & Molecular Biology

CAPE and its synthetic derivative VP961 restore BACH1/NRF2 axis in Down Syndrome

Sara Pagnotta, Antonella Tramutola, Eugenio Barone, Fabio Di Domenico, Valeria Pittala, Loredana Salerno, Valentina Folgiero, Matteo Caforio, Franco Locatelli, Stefania Petrini, D. Allan Butterfield, Marzia Perluigi

Summary: This study focuses on the role of BACH1/NRF2 ratio in the regulation of antioxidant response and its impact on patients with Down syndrome. The results show that overexpression of BACH1 disrupts the induction of antioxidant response genes, leading to oxidative damage accumulation. Additionally, administration of CAPE and VP961 promotes NRF2 nuclear translocation in cells from Down syndrome patients, improving antioxidant response.

FREE RADICAL BIOLOGY AND MEDICINE (2022)

Meeting Abstract Biochemistry & Molecular Biology

Loss Of Biliverdin Reductase-A (BVR-A) Impairs Brain Energy Metabolism Favoring The Development Of Neurodegeneration: A Link Between AD And T2DM

Chiara Lanzillotta, Antonella Tramutola, Fabio Di Domenico, Bindu Paul, Solomon Snyder, D. Allan Butterfield, Marzia Perluigi, Joao Duarte, Eugenio Barone

FREE RADICAL BIOLOGY AND MEDICINE (2022)

Meeting Abstract Biochemistry & Molecular Biology

The harmful relationship between redox homeostasis and protein quality control systems in Alzheimer-like pathology

Fabio Di Domenico, Chiara Lanzillotta, Eugenio Barone, Antonella Tramutola, Marzia Perluigi

FREE RADICAL BIOLOGY AND MEDICINE (2022)

Meeting Abstract Biochemistry & Molecular Biology

Intranasal Insulin Administration Reduces Oxidative Stress-Induced Damage And Improves Mitochondrial Bioenergetics In Alzheimer Disease

Antonella Tramutola, Sara Pagnotta, Fabio Di Domenico, Marzia Perluigi, Eugenio Barone

FREE RADICAL BIOLOGY AND MEDICINE (2022)

Article Neurosciences

Chronic treatment with the anti-diabetic drug metformin rescues impaired brain mitochondrial activity and selectively ameliorates defective cognitive flexibility in a female mouse model of Rett syndrome

Chiara Urbinati, Chiara Lanzillotta, Livia Cosentino, Daniela Valenti, Maria Cristina Quattrini, Livia Di Crescenzo, Francesca Prestia, Donatella Pietraforte, Marzia Perluigi, Fabio Di Domenico, Rosa Anna Vacca, Bianca De Filippis

Summary: Metformin treatment can selectively correct cognitive flexibility defects, improve mitochondrial function, and inhibit oxidative stress in female mice with Rett syndrome (RTT). However, it does not affect the general health and motor skills of RTT mice.

NEUROPHARMACOLOGY (2023)

Article Biochemistry & Molecular Biology

Intranasal Administration of KYCCSRK Peptide Rescues Brain Insulin Signaling Activation and Reduces Alzheimer's Disease-like Neuropathology in a Mouse Model for Down Syndrome

Antonella Tramutola, Simona Lanzillotta, Giuseppe Aceto, Sara Pagnotta, Gabriele Ruffolo, Pierangelo Cifelli, Federico Marini, Cristian Ripoli, Eleonora Palma, Claudio Grassi, Fabio Di Domenico, Marzia Perluigi, Eugenio Barone

Summary: Down syndrome (DS) is associated with Alzheimer's disease (AD) and brain insulin resistance. The KYCCSRK peptide has shown potential for improving insulin signaling in DS and reducing AD-like neuropathology in mice.

ANTIOXIDANTS (2023)

Meeting Abstract Biochemistry & Molecular Biology

DECIPHERING THE NOXIOUS RELATIONSHIP BETWEEN OXIDATIVE STRESS AND THE UNFOLDED PROTEIN RESPONSE IN ALZHEIMER-LIKE NEUROPATHOLOGY

Fabio Di Domenico

FREE RADICAL BIOLOGY AND MEDICINE (2022)

No Data Available